Dynamic MR imaging and radiotherapy

Magnetic Resonance in Medical Sciences

Volumn 1, Issue 1, 2002, Pages 32-37

  Baba, Yuji ^a   Yamashita, Yasuyuki ^a   Onomichi, Mitsukazu ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

MRI; Perfusion; Pharmacokinetic analysis; Radiation therapy; Tumor vascularity

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ALGORITHM; CANCER INVASION; DIFFERENTIAL DIAGNOSIS; FACTORIAL ANALYSIS; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW; UTERUS CANCER;

ALGORITHMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FACTOR ANALYSIS, STATISTICAL; FEMALE; GADOLINIUM DTPA; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM INVASIVENESS; UTERINE NEOPLASMS;

EID: 24144438681     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.1.32     Document Type: Review

References (33)

1. Zagdanski AM, Sigal R, Bosq J, Bazin JP, Vanel D, Di Paoia R, Factor analysis of medical image sequences in MRI of head and neck tumors. AJNR 1994;15:1359-1368
2. Escott EJ, Rao VM, Ko WD, Guitierrez JE, Comparison of dynamic contrast-enhanced gradientecho and spin-echo sequences in MR of head and neck neoplasms. AJNR 1997;18(8):1411-1419
3. Baba Y, Furusawa M, Murakami R, et al., Role of dynamic MRI in the evaluation of head and neck cancers treated with radiation therapy. Int J Radiat Oncol Biol Physi 1997;37(4):783-787
4. Takashima S, Noguchi Y, Okumura T, Aruga H, Kobayashi T, Dynamic MR imaging in the head and neck. Radiology 1993;189(3):813-821
5. Perman WH, el-Ghazzawy O, Gado MH, Larson KB, Perlmutter JS, A half-Fourier gradient echo technique for dynamic MR imaging. Magn Reson Imaging 1993;11(3):357-366
6. Hawighorst H, Knapstein PG, Schaeffer U, et al., Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions. AJR 1996;166(2): 401-408
7. Griebel J, Mayr NA, de Vries A, et al., Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. JMRI 1997;7:111-119
8. Murakami R, Baba Y, Nishimura R, Sakaguchi T, Furusawa M, Takahashi M, MR imaging of early glottic carcinoma: predictive value of local control with radiation therapy. Radiology 1998;209(P):477
9. Tofts PS, Kermode AG, Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357-367
10. Den Boer JA, Hoenderop RKKM, Smink J, et al., Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions. JMRI 1997;7:702-715
11. Mayr NA, YuhWTC, Magnotta VA, et al., Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 1996;36:623-633
12. Lamer S, Sigal R, Lassau N, et al., Radiologic assessment of intranodal vascularity in head and neck squamous cell carcinoma. Correlation with histologic vascular density. Investigative Radiology 1996;31(11):673-679
13. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al., Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nuclear Med 1995;36(10):1747-1757
14. Hawighorst H, Knapstein PG, Knopp MV, et al., Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of timeintensity curves for assessment of tumor angiogenesis and patient survival. Cancer Research 1998; 58(16):3598-3602
15. Delorme S, Knopp MV, Non-invasive vascular imaging: assessing tumour vascularity. Eur Radiology 1998;8(4):517-527
16. Su MY, Muhler A, Lao X, Nalcioglu O, Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn Reson Med 1998;39(2):259-269
17. Mussurakis S, Buckley DL, Bowsley SJ, et al., Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma. Investigative Radiology 1995;30(11): 650-662
18. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ, Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995;33(4):506-514
19. Knopp MV, Brix G, Junkermann HJ, Sinn HP, MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. [Review] [42 refs] Magn Reson Imaging Clinics North Am 1994;2(4): 633-658
20. Hawighorst H, Knapstein PG, Weikel W, et al., Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Research 1997;57(21):4777-4786
21. Hawighorst H, Engenhart R, Knopp MV, Intracranial meningeomas: time-and dose-dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imaging. Magn Reson Imaging 1997;15(4):423-432
22. Hawighorst H, Knapstein PG, Weikel W, et al., Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging. Radiology 1996; 201(2):531-539
23. Su MY, Najafi AA, Nalcioglu O, Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn Reson Med 1995;34(3):402-411
24. Su MY, Jao JC, Nalcioglu O, Measurement of vascular volume fraction and blood-tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI. Magn Reson Med 1994;32(6):714-724
25. Fujii K, Fujita N, Hirabuki N, Hashimoto T, Miura T, Kozuka T, Neuromas and meningiomas: evaluation of early enhancement with dynamicMR imaging. AJNR 1992;13:1215-1220
26. Maeda M, Itoh S, Kimura H, et al., Vascularity of meningiomas and neuromas: assessment with dynamic susceptibility-contrast MR imaging. AJR 1994;163:181-186
27. Maeda M, Itoh S, Kimura H, et al., Tumor vascularity in the brain: evaluation with dynamic susceptiblity-contrast MR imaging. Radiology 1993;189:233-238
28. Beaney RP, Lammertsma AA, Jones T, NcJenzie CG, Halnan KE, Positron emission tomography for in-vivo measurement of regional blood flow, oxygen utilisation, and blood volume in patients with breast carcinoma. Lancet 1984;1:131-134
29. 2-histography. Int J Radiat Oncol Biol Phys 1990;19:953-961
30. Urtasun RC, Chapman JD, Raleigh JA, Franko AJ, Koch CJ, Binding of H-3 misonidazole to solid human tumors as a measure of tumor hypoxia. Int J Radiat Oncol Biol Phys 1986; 12:1263-1267
31. Baba Y, Yamashita Y, Onomichi M, Murakami R, Takahashi M, Dynamic magnetic resonance imaging of head and neck lesions. Topics in Magn Reson Imaging 1999;10(2):125-129
32. Yamashita Y, Baba T, Baba Y, et al., Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology 2000;216(3):803-809
33. Murakami R, Baba Y, Furusawa M, et al., Early glottic squamous cell carcinoma. Predictive value of MR imaging for the rate of 5-year local control with radiation therapy. Acta Radiologica 2000; 41(1):38-44